CD30 differential staining is useful in classifying lymphomas intermediate between Hodgkin's disease and anaplastic

U Schmidt1, K A Metz, U Möser

  • 1Department of Pathology, University of Essen, Germany.

Tumori
|March 18, 1999
PubMed
Abstract